Russia will have its first quadrivalent influenza vaccine

According to the experts, this vaccine has not only the most effective and safe profile possible today, but also provides undeniable pharmacoeconomic advantages.

A memorandum signed to promote Russian products onto the Chilean market

The representatives of the Public Health Institute of Chile visited a vaccine production facility of St. Petersburg Institute of Vaccines and Serums in order to continue and expand cooperation between Russia and Chile.

St. Petersburg Institute of Vaccines and Serums joins DCVMN

In November 2017, St. Petersburg Institute of Vaccines and Serums joined the Developing Countries Vaccine Manufacturers Network

Chile interested in expanding cooperation with St. Petersburg Research Institute

A meeting between the representatives of Instituto de Salud Pública, Chile, and St. Petersburg Research Institute of Vaccines and Serums was held in St. Petersburg.

Russia enters the market of TB diagnosis services in Latin America

In early August, the first lot of Russian-made diagnostic drug for detecting TB at early stages was delivered to Cuba.